Transparency: C

Disclosure or product name

2.2

In all APS for pharmaceutical products, the brand or trade name, the non-proprietary or generic name and the Federal drug schedule of the product must appear in juxtaposition at least once within advertising copy and must be in good contrast and be legible. For example PRARBACE™ (Arbasartin Sodium). The Federal drug schedule is not required to be disclosed for non-prescription products.